<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 10 Mar 2021 11:37:35 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>珠璧联辉丨和元生物与康晟生物就Wayne293™宿主细胞平台及高产毒衍生细胞株共同开发达成战略合作</title><link>https://mp.weixin.qq.com/s/WXjGjpN9dj_dLT75hzPLtg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/gxB1svTgKicY39jVKcZmOysmNCq1xKcC7XlqXZicufFJCoGLVh0xU7eDTiadWdNv4niaqfT2BDnmGESbkye2l7wMyQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>推动中国地区细胞治疗与基因治疗行业快速发展]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>新型免疫治疗系列直播预告丨Cytiva携手知名CDMO打造生物制药工艺系列线上课程</title><link>https://mp.weixin.qq.com/s/E634aJeqA-bNXvR9PRhlLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMehJT1BPNjV9XbCuK9RxbvhIoxjZyWEI0hXeDWibWfOnwVbHd0ytesfw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月11起每周四晚19:30，直播间不见不散！]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>FDA曾拒绝的A型血友病基因疗法，如今再获再生医学先进疗法指定丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/ToheQiXxaGVeddwLed6Xng</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMLgQvcYgp3XTWIfn57Rc0UY4BBoySibFx0unGMjlNwiaN5AEA9WIaeXDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>A型血友病基因疗法研发赛道，你追我赶。]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>EpCAM靶向ADC向欧洲递交上市申请，预计2022年初获批丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/OKAAuu2lW4cBPfTBJ64qXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMQiaOJptURntWcxjiaegoicKbjqswLphKCA9a7w8rjxZYhlAmDHaLV0ibRA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ADC未来可期]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>药融资丨澳斯康生物制药完成超4亿元人民币C轮融资</title><link>https://mp.weixin.qq.com/s/6XzNNoa34AkTZAUJFF_HYw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMgakGmCkS9JVkX3ZSG967AIiao8ibT74aXrI6GtsFCiat47djcbFGUs0ZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本轮融资将有助于打造全球最大的培养基生产基地和国际领先的CDMO平台]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>2020年细胞疗法监管政策回顾，细胞疗法走向正轨丨医麦新观察</title><link>https://mp.weixin.qq.com/s/qS6TJMeCg4AbEwUxR1Hkcg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYht4lmLPU6O5fOPU8dPpNoGwPiafSub60Oc75plYXc459sp7GUvdwHCYsw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>火热的细胞疗法]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>新型CAR-T技术获得欧洲专利，针对卵巢癌的临床研究即将启动丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/FtRIWhT5mmQZKCm4c6G9eQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMmWvhI0bCcFojS5wqibsibZkRyKPbYiatwib9uNfos5Yys9vgwWS21RfOYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>向实体瘤发起挑战]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>装甲溶瘤腺病毒已经完成首例患者给药，表达OX40L配体增强肿瘤杀伤效果丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Bzw0h4bW8dgsPzQV64FDGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtzFvYJGBk8QjoGxoLkUnktcN897L6Pa5Q1BWtGERlFqt6xDKSVEYYow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>溶瘤病毒是联合治疗策略中的理想对象，成为肿瘤免疫研究中的热门方向]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>重磅！美国FDA加速批准Yescarta第二个适应症丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/6Y_jbcgYBt2boAH03-j-jg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtmI25RWpQBIUaPpWqDILh3MjhgAXIJgQ01SLsic4ve4NjdMQJEENZHjA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Yescarta全球布局]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>药融资丨拜耳支持的iPSC公司完成1.6亿美元C轮融资，加快iPSC衍生疗法开发</title><link>https://mp.weixin.qq.com/s/unmDHuDpa4fkaT3BaS1pFQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6KQUlD2q6cGYrEiba5b7119jiaiaDYBwCDhep2IShKbkd2WfeGQrDGBKM1pd2Xn9kRSz6RiakLXWOFUw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>iPSC巨大潜力]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>优卡迪首款创新型CAR-T药物临床试验启动会顺利召开丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/bCNdmNGjSudpt1O24zxdRw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtzHYKgrDpVHPQWBzHHOLrnFZhiagLEFSMCdBbbxKcnkSWfYkHx5GVlHw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>以CD19为靶点，同时携带IL-6沉默元件的CAR-T]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:57:49 +0800</pubDate></item><item><title>脱发吗？先别植发，来看看干细胞治疗的神奇之处丨医麦新观察</title><link>https://mp.weixin.qq.com/s/xWseFVvlHUnVVjRfn8HjdA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtdj952viamc3EEVJdOXJc0jHmRtO16mmdtbWIMH2DlFBpNpO9ibtlNrkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预防脱发和促进毛发再生效果显著]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:57:49 +0800</pubDate></item><item><title>获350万欧元融资，Treg细胞疗法成为移植排斥患者新希望丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/9NVM8CHiOlFxZDxk4WQx4A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtDDBQyAhsw4ErpwuibgrbhIfkZtEhuwxNbWjMfV5TpJeCGYC0hH5o4XQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Treg细胞治疗将成为抗排斥、抗炎和致耐受性疗法发展的热门风向标]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:57:49 +0800</pubDate></item><item><title>HIV患者长期获益！CCR5基因编辑T细胞疗法重建免疫功能丨医麦黑科技</title><link>https://mp.weixin.qq.com/s/P_51XvxrMVtI8kqFhHd79w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvsz5q8oQIleKibF4YB1KqJP8A5TRgicicEaBGVzjBG6IXdpBFgYMUkG2u06pPzDlcejTM0SNbc6sfvg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>逆转艾滋病患者命运！]]></content:encoded><pubDate>Sat, 06 Mar 2021 20:10:37 +0800</pubDate></item><item><title>药融资丨一周融资交易盘点，拜耳、安进、百健</title><link>https://mp.weixin.qq.com/s/ikQErH7vZQ50jqJkh7xIpw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuU4Lu3wrVygdXt6S8qphictRagIgoc0qbNPzuPv8iadXuHT8zicdk7tnjrfjwtAsib5IncObicjHQNF9g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本周医药领域重大融资事件]]></content:encoded><pubDate>Sat, 06 Mar 2021 20:10:37 +0800</pubDate></item><item><title>洞见PD-1后时代的三大趋势丨峰客浅析</title><link>https://mp.weixin.qq.com/s/jWBwOj9t0trWemACsVa7Xg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItl4wsRs1FKhl4oBia5aq6OUibxwJJf9d7BjEhCIibADccGPLSILjLsJiaOljN6UIjLYw3MJicrSVoPVwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 浅析专栏]]></content:encoded><pubDate>Sat, 06 Mar 2021 20:10:37 +0800</pubDate></item><item><title>国际骨髓瘤关爱月丨骨髓瘤患者又将迎来一种治疗选择</title><link>https://mp.weixin.qq.com/s/HVe4P4cRiwnteqdJTCQxWw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuU4Lu3wrVygdXt6S8qphictPNUrmEQtyv3Lyk43DBbOKniaLNpFtP0iaFpYCL4l2x262XDvBgbSzueA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新的CAR-T治疗方案可能给骨髓瘤患者带来新的治疗选择。]]></content:encoded><pubDate>Fri, 05 Mar 2021 22:38:06 +0800</pubDate></item><item><title>药融资丨安进19亿美元收购Five Prime获得FGFR2b抗体，再鼎医药手握该抗体大中华权益</title><link>https://mp.weixin.qq.com/s/1XakKpbOGgWzIFphNLM2Ew</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuU4Lu3wrVygdXt6S8qphictT5rEdRgBq9CS5v12y6UvCWiaZINmSdFiac69PC1JkxiaKicKb5zdP5piahA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>买买买]]></content:encoded><pubDate>Fri, 05 Mar 2021 22:38:06 +0800</pubDate></item><item><title>首款宫血来源间充质干细胞申报临床丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/p4bLlcCjijW52MWiOvqrMg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuU4Lu3wrVygdXt6S8qphictlDgXUAF3fr8OAf6x5etgFnhbThhASoyNOjBjG4qZR2Vmib52a2kSkpg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>干细胞技术被誉为继药物治疗和手术治疗之后的第三次医学革命]]></content:encoded><pubDate>Fri, 05 Mar 2021 22:38:06 +0800</pubDate></item><item><title>药融资丨诺奖得主联合创办的CRISPR公司完成1.15亿美元C轮融资，艾伯维参与投资</title><link>https://mp.weixin.qq.com/s/4moa_QkUYK4YB3mMsJguig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6KQUlD2q6cGYrEiba5b7119YlP3fbV8iago890znlChykNCYe1PibibotoBqwTNehvRcaDVpbBOKPYcg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>投资风向]]></content:encoded><pubDate>Fri, 05 Mar 2021 22:38:06 +0800</pubDate></item></channel></rss>